News | Oncology Diagnostics | February 06, 2019

Oxford University Hospitals Employs Barco Synergi for Multi-disciplinary Cancer Conferences

NHS Foundation Trust implements clinical collaboration technology from Barco to streamline tumor boards

Oxford University Hospitals Employs Barco Synergi for Multi-disciplinary Cancer Conferences

February 6, 2019 — Oxford University Hospitals (OUH) is trialing clinical collaboration technology from Barco for its Multi-disciplinary Cancer Conferences. The primary focus of this cooperation is to streamline the preparation, management and follow-up of these meetings. With the Barco Synergi solution, preparation for the conference is more efficient, the meeting experience is seamless for both local and remote participants, and critical follow-up actions are handled promptly.

Multi-disciplinary Cancer Conferences (also called tumor boards or multi-disciplinary team meetings) are designed to ensure the best patient outcomes by bringing the clinical care team together to discuss all applicable diagnostic tests, suitable treatment options and treatment recommendations for each cancer patient.

Multi-disciplinary team meetings (MDTs) in cancer are the most expensive meetings per hour in the U.K. National Health System (NHS) due to the wide range of experts involved, and the need to bring together a wide variety of information; this includes patient records, imaging, pathology slides, cancer staging and genetic testing.

Nick Maynard, the OUH lead for cancer, said: “We have worked with Barco to develop a tool that can collect and organize the information and data so it is easily presented and understood. It will also enable the rapid transfer, by automated electronic notification, of the outcome of the MDT discussion and decisions made to all staff involved in the patient’s care.”

The Barco Synergi technology addresses the challenge of pulling together all the relevant patient case information for discussion during cancer conferences. Barco’s cloud-based software solution gathers all relevant patient data, documents the stage of the patient's tumor, and makes it easy to share this information with the entire care team.

It provides an intuitive, fast and secure way to share any images and other patient information from any workstation with the team, eliminating the need to transfer images from one site to the other for the sake of the meeting. “In-meeting approval” of treatment recommendation by the meeting chair and automated upload of the treatment outcome to the Cerner Millennium electronic health record (EHR), results in quick scheduling of the treatment for the patients, thus reducing patient wait times.

Continuous visibility of all this critical patient information, as well as the recommended outcome of every patient being discussed, enables flexible planning of every cancer team member around the patient resulting in huge efficiency gains.

Maynard added, “We believe this will lead to not only a significant improvement in the efficiency of the MDT meetings, but also a significant reduction in the time between referral of the patient and commencement of treatment. This tool also records and analyzes MDT performance and outcomes in real-time, enabling us to identify service improvements rapidly.”

The trialing of the new system has been supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, which aims to translate medical innovation into clinical benefits for patients.

For more information: www.barco.com

Related Content

Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
HHS Extends Comment Period for Proposed Electronic Health Information Interoperability Rules
News | Electronic Medical Records (EMR) | April 19, 2019
The U.S. Department of Health and Human Services (HHS) is extending the public comment period by 30 days for two...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care
News | Artificial Intelligence | April 18, 2019
Atrium Health patients will now be able to use Amazon’s electronic voice system Alexa to not only locate the nearest...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...